This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Children from the United Kingdom admitted to the hospital during a 5-month study period with acute asthma were enrolled in a randomized, controlled study. Patients were excluded if they were less than 3 years, needed intravenous beta agonist therapy, couldn’t use a spacer mouthpiece effectively or were readmitted during the 5-month study period. Thirty-three control children (mean age, 8 years) received nebulized salbutamol (5 mg up to hourly by jet nebulizer driven by oxygen at 6–8 L/min) while 29 children (mean age, 6.9 years) received salbutamol from a metered dose …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.